Oragenics Inc Share Price Nyse
Equities
US6840232036
Biotechnology & Medical Research
Sales 2022 | 0.13 10.98 | Sales 2023 | 0.04 3.14 | Capitalization | 14.46M 1.21B |
---|---|---|---|---|---|
Net income 2022 | -14M -1.17B | Net income 2023 | -20M -1.67B | EV / Sales 2022 | 1,18,42,208 x |
Net cash position 2022 | 10.8M 902M | Net cash position 2023 | 3.16M 264M | EV / Sales 2023 | 29,99,79,895 x |
P/E ratio 2022 |
-0.89
x | P/E ratio 2023 |
-0.61
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.77% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Redmond
CEO | Chief Executive Officer | 64 | 28/12 |
Janet Huffman
DFI | Director of Finance/CFO | 52 | 07/23/07 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Pope
CHM | Chairman | 73 | 04/10/04 |
John Gandolfo
BRD | Director/Board Member | 63 | 04/23/04 |
Robert Koski
BRD | Director/Board Member | 65 | 30/09/30 |
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.46% | 21.25B | |
-5.71% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |